Starpharma Holdings Ltd. SPHRY Company Overview  Stock

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Starpharma Holdings Ltd. SPHRY Company Overview 

Stock Message Board http://investorshangout.com/search?q=SPHRY&am...mp;yt1=Go!

Starpharma Holdings Ltd. SPHRY Current Price and Quotes
Last Price 9.57
Previous Close 9.57 Open 9.57
Daily Range 9.57 - 9.57 52wk Range 17.92 - 7.11
Volume 100 Dividend N/A
Average Vol (3m) 1,846 Yield N/A
Starpharma Holdings Ltd. SPHRY

Company Verified Profile
Company Information

Baker IDI Building
75 Commercial Road
Melbourne, VIC 3004
Australia

Website: http://www.starpharma.com
Phone: +61 3 8532 2700

Starpharma Holdings Ltd. SPHRY
Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY), located in Melbourne Australia, is an ASX 300 company and is a world leader in the development of dendrimer products for pharmaceutical, life science and other applications. Starpharma's underlying technology is built around dendrimers- a type of synthetic nanoscale polymer that is highly regular in size and structure and well suited to pharmaceutical uses. Starpharma has three core development programs: VivaGel portfolio, drug delivery, and a...



Starpharma Holdings Ltd. SPHRY
Financial Reportings and Disclosures

Reporting Status International Reporting: ASX - Australian Securities Exchange
Audited Financials Audited
Latest Report Jun 30, 2013 Quarterly Report
CIK 0001308380
Fiscal Year End 6/30
OTC Marketplace OTCQX International
Profile Data

SIC - Industry Classification 8731 - Commercial physical research
Incorporated In: Australia
Year of Inc. 1997
Employees 30 a/o Jul 01, 2011
Company Officers/Contacts

Dr. Jackie Fairley CEO, IR, Managing Director
Nigel Baade CFO
Ben Rogers Secretary
Company Directors

Peter Bartels Chairman
Richard Hazleton
Dr. Peter Jenkins
Zita Peach
Peter Turvey
Company Notes

Formerly=Starpharma Pooled Development Ltd. until 4-04
Service Providers

DAD/PAL
BNY Mellon
101 Barclay Street
22nd Floor
New York, NY, 10286
United States

Auditor/Accountant
PricewaterhouseCoopers
Itamerentori 2
Helsinki, 00100
Finland

Legal Counsel
Not Available
Investor Relations Firm
Not Available

Starpharma Holdings Ltd. SPHRY
SPHRY Security Details Other Company Securities

Share Structure

Market Value1 $271,658,755 a/o Sep 27, 2013
Shares Outstanding 283,864,948 a/o Jul 12, 2013
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders

Shareholders of Record Not Available
Non US Stock Exchange Listing

SPL - ASX - Australian Securities Exchange - Qualified
Short Selling Data

Short Interest 4,181 (-44.54%)
Sep 13, 2013
Significant Failures to Deliver  No
Transfer Agent(s)

BNY Mellon

Starpharma Holdings Ltd. SPHRY Recent News

Starpharma Holdings Ltd. SPHRY Financials
Period Ending Jun 30, 2013 Jun 30, 2012
Total Revenue 2,223 2,813
Cost of Revenue - -
Gross Profit 2,223 2,813
Operating Expenses

Research and Development 3,208 12,391
Sales, General and Admin. 3,793 4,414
Non-Recurring Items - -
Other - -
Operating Income (4,778) (13,992)
Income From Continuing Operations

Add'l Income/Expense Items - -
Earnings Before Interest and Tax (4,778) (13,992)
Interest Expense 8 8
Earnings Before Tax (4,786) (14,000)
Income Tax - -
Minority Interest - -
Equity Earnings Unconsolidated Subsidiary - -
Net Income Cont. Operations (4,786) (14,000)
Non Recurring Events

Discontinued Operations - -
Extraordinary Items - -
Effect of Accounting Changes - -
Other Items - -
Net Income (4,786) (14,000)
Preferred Stock and Other Adjustments - -
Net Income Applicable to Common Shareholders (4,786) (14,000)

SPHRY Starpharma Holdings Ltd. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=SPHRY&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/SPHRY/quote
Stock Chart http://www.otcmarkets.com/stock/SPHRY/chart
Company Info http://www.otcmarkets.com/stock/SPHRY/company-info
Recent News http://www.otcmarkets.com/stock/SPHRY/news
Financials http://www.otcmarkets.com/stock/SPHRY/financials
Filings and Disclosure http://www.otcmarkets.com/stock/SPHRY/filings
Short Sales http://www.otcmarkets.com/stock/SPHRY/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/SPHRY/insider-transactions
Research Reports http://www.otcmarkets.com/stock/SPHRY/research
Summary http://finance.yahoo.com/q?s=SPHRY
Historical Prices http://finance.yahoo.com/q/hp?s=SPHRY+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=SPHRY
Basic Chart http://finance.yahoo.com/q/bc?s=SPHRY+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=SPHRY+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=SPHRY+Headlines
Press Releases http://finance.yahoo.com/q/p?s=SPHRY+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=SPHRY+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=SPHRY+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=SPHRY+Industry
Major Holders http://finance.yahoo.com/q/mh?s=SPHRY+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=SPHRY+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=SPHRY+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=SPHRY
Balance Sheet http://finance.yahoo.com/q/bs?s=SPHRY
Cash Flow http://finance.yahoo.com/q/cf?s=SPHRY+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/SPHRY
Market Watch http://www.marketwatch.com/investing/stock/SPHRY
Bloomberg http://www.bloomberg.com/quote/SPHRY:US
Morningstar http://quotes.morningstar.com/stock/s?t=SPHRY
Bussinessweek http://investing.businessweek.com/research/st...cker=SPHRY
Barchart http://www.barchart.com/quotes/stocks/SPHRY
OTC Short Report http://otcshortreport.com/index.php?index=SPHRY
Investopedia http://www.investopedia.com/markets/stocks/SPHRY/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Investigation of Stock Transactions: TASK, VBTX, TURN Insights

Updated Category News Views 125

Financial Investigations for Shareholders of TASK, VBTX, and TURN Halper Sadeh LLC is actively investigating several companies regarding potential violations of federal securities laws affecting shareholders. The investigations focus on significant transactions involving TaskUs, Veritex Holdings, and 180 Degree Capital Corp. TaskUs, Inc. and Its Acquisition by Blackstone...

Continue Reading
Comprehensive Analysis of NVIDIA in the Semiconductor Market

Updated Category News Views 678

Understanding NVIDIA's Position in the Semiconductor Sector In today's fast-paced business environment, it is crucial for investors and industry followers to conduct in-depth analyses of key companies. This article offers a detailed comparison of NVIDIA (NASDAQ: NVDA) with its main competitors in the Semiconductors & Semiconductor Equipment sector. By looking at important...

Continue Reading
Invivyd Set to Showcase PEMGARDA™ Findings at Upcoming Event

Updated Category News Views 54

Invivyd Prepares for IDWeek 2024 Presentations Invivyd, Inc. (NASDAQ: IVVD) is an innovative biopharmaceutical company focusing on creating solutions for serious viral infections. As they gear up for their participation in IDWeek 2024, they will be unveiling exciting new data concerning their investigational monoclonal antibody, PEMGARDA™ (pemivibart). The conference is...

Continue Reading
The Rising Stars: Growth Potential of Key Investments

Updated Category News Views 95

Carnival made waves post-pandemic as it clawed its way back from meme stock purgatory. Traders watched the cruise line stumble but now see flickers of recovery amidst hefty debt burdens that peaked around $35 billion. Sure, they pulled in a whopping $1.7 billion net income in the last quarter, but those profit forecasts? All over the place—talk about a mixed bag. And...

Continue Reading
PharmAla Partners with Logistics Expert for Clinical Trials

Updated Category News Views 114

PharmAla Forms Strategic Alliance for Enhanced US Distribution PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a dedicated biotechnology company, is excited to share its latest strategic move aimed at improving service delivery in the United States. The company has engaged a trusted third-party logistics partner, specialized...

Continue Reading